FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 4131634 · Received October 1, 2014

Report

Report Number
2124215-2014-14275
Event Type
Injury
Date Received
October 1, 2014
Date of Event
July 10, 2014
Report Date
July 25, 2014
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

(B)(4). THIS LEAD HAS BEEN RETURNED. BOSTON SCIENTIFIC HAS CONCLUDED IT IS UNLIKELY THAT LEAD CHARACTERISTICS CAUSED OR CONTRIBUTED TO THE REPORTED CLINICAL OBSERVATIONS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS GREATER THAN 125 OHMS, LOW OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS LESS THAN 20 OHMS AND DECREASED R-WAVE MEASUREMENTS. ADDITIONALLY, RV UNDERSENSING AND OVERSENSING WAS OBSERVED THAT RESULTED IN INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) AND SHOCK THERAPY. THE LEAD WAS OBSERVED TO HAVE DISLODGED. IT WAS REPORTED THAT THE PATIENT SUFFERED FROM TWIDDLER'S SYNDROME. AN INVASIVE PROCEDURE WAS PERFORMED. THE RV LEAD WAS EXPLANTED AND REPLACED AND THIS ICD REMAINS IMPLANTED AND IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
613105 ENDOTAK RELIANCE NVY CPI - DEL CARIBE 0293

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| L| R 0293| E140